Silence Therapeutics plc — Form D

Silence Therapeutics plc of LONDON, X0, a company, filed a Form D exempt-offering notice with the SEC on 2010-01-05. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (20)

NameRoleLocation
Bernd Curnock WetzelDirectorLondon, X0
James Ede-GolightlyDirectorLondon, X0
Alistair GrayDirectorLondon, X0
Craig ToomanExecutive OfficerLondon, X0
Dave LemusDirectorLondon, X0
Giles CampionExecutive OfficerLondon, X0
Romano StevenDirectorLondon, X0
Michael H DavidsonDirectorLondon, X0
Mark RotheraDirectorLondon, X0
Mark RotheraExecutive OfficerLondon, X0
Iain RossDirectorLondon, X0
Iain RossExecutive OfficerLondon, X0
Barbara RuskinExecutive OfficerLondon, X0
Jeremy Curnock CookDirectorMontreal, A8
Melvyn Curnock DaviesDirectorLondon, X0
Melvyn Curnock DaviesExecutive OfficerLondon, X0
Annette ClancyDirectorLondon, X0
Peter Curnock ReynoldsDirectorLondon, X0
David Curnock U'PrichardDirectorLondon, X0
Jerry Curnock RandallDirectorLondon, X0

Other filings by this issuer (3)

FiledFormOfferingSold
2021-02-18D$45.5M$45.5M
2010-01-05D
2010-01-05D$8.5M

More